Healthtech funding in February 2021
European Healthtech startup funding raised during February 2021.
In February 2021, 27 European Healthtech companies closed 27 funding rounds and raised €286M in equity funding (excluding debt and grants), down 21.7% versus February 2020. Debt rounds added €190M. UK led by capital raised, and Asabys Partners was the most active investor. Data as of 20 Nov 2026.
Equity funding
€286M
-21.7% vs February 2020 · excl. debt & grants · +€190M debt
Funding rounds
27
-27.0% vs February 2020
Companies
27
Top country
UK
Rank among sectors
#7
5.2% of sector funding
Debt financing
€190M
39.9% of total
Top-10 round share
89.7%
of disclosed capital
Rounds ≥ €100M
1
Top countries
by € raisedHealthtech — top countries by capital, February 2021 — interactive chart.
Data table
| Healthtech — top countries by capital, February 2021 | |
|---|---|
| UK | €321M |
| Spain | €73M |
| Portugal | €21M |
| Israel | €20M |
| France | €17M |
| Netherlands | €12M |
| Sweden | €11M |
| Germany | €1.5M |
Stage mix
by € raisedHealthtech — stage mix, February 2021 — interactive chart.
Data table
| Healthtech — stage mix, February 2021 | |
|---|---|
| Debt | €190M |
| Other | €121M |
| Series C | €80M |
| Series A | €40M |
| Series B | €21M |
| Seed | €17M |
| Crowdfunding | €6.7M |
| Pre-Seed | €535k |
| Grant | €401k |
Top deals
largest disclosed rounds in February 2021| Company | Stage | Date | Amount |
|---|---|---|---|
| Immunocore | Debt | Feb 2021 | €190M |
| Evox Therapeutics | Series C | Feb 2021 | €80M |
| Koa Health | Other | Feb 2021 | €30M |
| SpyBiotech | Series A | Feb 2021 | €27M |
| Highlight Therapeutics | Other | Feb 2021 | €23M |
| Sword Health | Series B | Feb 2021 | €21M |
| Medlumics | Other | Feb 2021 | €18M |
| Wren Therapeutics | Other | Feb 2021 | €14M |
| Theator | Series A | Feb 2021 | €13M |
| Founda Health | Seed | Feb 2021 | €12M |
| eConsult Health | Other | Feb 2021 | €8.0M |
| Virility Medical | Crowdfunding | Feb 2021 | €6.7M |
| AcuSurgical | Other | Feb 2021 | €5.8M |
| TokTokDoc | Other | Feb 2021 | €5.0M |
| EnginZyme | Other | Feb 2021 | €4.6M |
Top investors
most active in February 2021, by deal count- Asabys Partners1 deals
- Braavos Capital1 deals
- btov Partners1 deals
- Industrifonden1 deals
- Innovate UK1 deals
- Insight Partners1 deals
- Mérieux Equity Partners1 deals
- Oxford Finance LLC1 deals
- Redmile Group1 deals
- Rhythm VC1 deals